Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Parabilis Medicines Inc | 4,615,612 | 4,615,612 | 0 | $126.33M | $149.04M | 10.01% | +$22.71M |
| Praxis Precision Medicines, Inc.(PRAX) | 640,000 | 500,000 | -140,000 | $214.27M | $145.62M | 9.78% | -$68.65M |
| Rapport Therapeutics, Inc.(RAPP) | 2,657,521 | 2,457,521 | -200,000 | $110.74M | $82.57M | 5.54% | -$28.17M |
| Edgewise Therapeutics, Inc.(EWTX) | 2,510,000 | 1,860,000 | -650,000 | $101.98M | $75.52M | 5.07% | -$26.47M |
| Bridgebio Oncology Therapeut | 17,878,594 | 17,878,594 | 0 | $136.23M | $73.30M | 4.92% | -$62.93M |
| Erasca, Inc.(ERAS) | 6,000,000 | 5,000,000 | -1,000,000 | $109.92M | $73.30M | 4.92% | -$36.62M |
| Blossomhill Therapeutics Inc | 0 | 3,614,034 | +3,614,034 | $0 | $67.37M | 4.52% | +$67.37M |
| Adlai Nortye Group LtdADS | 3,978,229 | 3,978,229 | 0 | $45.75M | $63.65M | 4.27% | +$17.90M |
| Dianthus Therapeutics, Inc.(DNTH) | 750,000 | 500,000 | -250,000 | $73.11M | $44.02M | 2.96% | -$29.09M |
| ABIVAX Société AnonymeADS(ABVX) | 675,000 | 425,000 | -250,000 | $89.95M | $42.08M | 2.83% | -$47.87M |
| Bright Minds Biosciences Inc | 900,000 | 800,000 | -100,000 | $63.18M | $39.86M | 2.68% | -$23.32M |
| Electra Therapeutics Inc | 0 | 3,365,533 | +3,365,533 | $0 | $37.86M | 2.54% | +$37.86M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 3,205,433 | 2,855,433 | -350,000 | $62.41M | $33.41M | 2.24% | -$29.00M |
| Oruka Therapeutics, Inc.(ORKA) | 533,340 | 400,000 | -133,340 | $50.76M | $33.32M | 2.24% | -$17.44M |
| Attovia Therapeutics Inc | 0 | 1,788,815 | +1,788,815 | $0 | $30.66M | 2.06% | +$30.66M |
| Faeth Therapeutics Inc | 1,028,242 | 1,028,242 | 0 | $7.66M | $30.58M | 2.05% | +$22.92M |
| Latigo Biotherapeutics Inc | 0 | 1,815,740 | +1,815,740 | $0 | $30.32M | 2.04% | +$30.32M |
| Agomab Therapeutics NvADS | 2,465,348 | 2,465,348 | 0 | $32.00M | $27.37M | 1.84% | -$4.63M |
| Opus Genetics Inc | 0 | 5,500,000 | +5,500,000 | $0 | $26.62M | 1.79% | +$26.62M |
| Climb Bio Inc | 2,106,000 | 2,106,000 | 0 | $27.46M | $24.16M | 1.62% | -$3.31M |
| Freenome Inc | 0 | 1,431,032 | +1,431,032 | $0 | $22.54M | 1.51% | +$22.54M |
| MBX Biosciences, Inc.(MBX) | 550,000 | 375,000 | -175,000 | $30.36M | $21.98M | 1.48% | -$8.38M |
| Biohaven Ltd.(BHVN) | 2,610,000 | 1,510,000 | -1,100,000 | $38.84M | $20.16M | 1.35% | -$18.68M |
| Adarx Pharmaceuticals Inc | 0 | 962,898 | +962,898 | $0 | $19.20M | 1.29% | +$19.20M |
| Eyepoint Inc | 7,000,000 | 5,750,000 | -1,250,000 | $100.10M | $18.80M | 1.26% | -$81.30M |
| Tango Therapeutics, Inc.(TNGX) | 1,300,000 | 700,000 | -600,000 | $40.64M | $17.46M | 1.17% | -$23.17M |
| Damora Therapeutics Inc | 0 | 800,000 | +800,000 | $0 | $17.02M | 1.14% | +$17.02M |
| BridgeBio Pharma, Inc.(BBIO) | 550,000 | 250,000 | -300,000 | $40.96M | $16.45M | 1.10% | -$24.51M |
| Cue Biopharma Inc | 0 | 625,285 | +625,285 | $0 | $16.18M | 1.09% | +$16.18M |
| Corbus Pharmaceuticals Hldgs | 2,344,971 | 2,344,971 | 0 | $22.00M | $15.99M | 1.07% | -$6.00M |
| Bioage Labs Inc | 2,390,605 | 2,240,605 | -150,000 | $58.59M | $15.89M | 1.07% | -$42.71M |
| Alumis Inc | 3,285,596 | 2,075,000 | -1,210,596 | $92.46M | $15.33M | 1.03% | -$77.12M |
| Olema Pharmaceuticals Inc | 2,150,000 | 1,750,000 | -400,000 | $26.90M | $15.12M | 1.02% | -$11.78M |
| Pharvaris N V COM | 750,000 | 450,000 | -300,000 | $25.93M | $14.27M | 0.96% | -$11.66M |
| Helix Acquisition Corp IiiCL A | 1,297,500 | 1,297,500 | 0 | $13.81M | $13.78M | 0.93% | -$25.9K |
| Spyre Therapeutics, Inc.(SYRE) | 225,000 | 125,000 | -100,000 | $19.98M | $11.13M | 0.75% | -$8.85M |
| Definium Therapeutics, Inc.(DFTX) | 400,000 | 275,000 | -125,000 | $18.82M | $10.47M | 0.70% | -$8.35M |
| Aclaris Therapeutics Inc | 0 | 1,750,000 | +1,750,000 | $0 | $9.21M | 0.62% | +$9.21M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 200,000 | 300,000 | +100,000 | $3.59M | $8.73M | 0.59% | +$5.14M |
| Cabaletta Bio Inc | 5,000,000 | 4,500,000 | -500,000 | $15.55M | $8.64M | 0.58% | -$6.91M |
| Inhibrx Biosciences, Inc.(INBX) | 0 | 50,000 | +50,000 | $0 | $5.00M | 0.34% | +$5.00M |
| Kailera Therapeutics Inc | 550,000 | 400,000 | -150,000 | $12.12M | $4.57M | 0.31% | -$7.55M |
| Jade Biosciences Inc | 0 | 300,000 | +300,000 | $0 | $4.21M | 0.28% | +$4.21M |
| Ibio Inc | 3,570,000 | 3,570,000 | 0 | $6.25M | $4.21M | 0.28% | -$2.03M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 100,000 | 50,000 | -50,000 | $6.29M | $3.93M | 0.26% | -$2.36M |
| Roivant Sciences Ltd.SHS(ROIV) | 475,000 | 100,000 | -375,000 | $16.81M | $3.66M | 0.25% | -$13.15M |
| Enliven Therapeutics Inc | 150,000 | 75,000 | -75,000 | $7.61M | $3.44M | 0.23% | -$4.17M |
| Ascendis Pharma A/S(ASND) | 50,000 | 15,000 | -35,000 | $13.34M | $3.42M | 0.23% | -$9.92M |
| Odyssey Therapeutics Inc | 175,000 | 125,000 | -50,000 | $3.27M | $2.78M | 0.19% | -$496.8K |
| Newamsterdam Pharma Company ORDINARY SHARES | 500,000 | 100,000 | -400,000 | $16.95M | $2.43M | 0.16% | -$14.51M |
| Boundless Bio Inc | 1,000,000 | 940,000 | -60,000 | $2.50M | $2.36M | 0.16% | -$140.6K |
| Insmed Incorporated(INSM) | 75,000 | 20,000 | -55,000 | $8.00M | $2.28M | 0.15% | -$5.71M |
| Braveheart Bio Inc | 0 | 70,000 | +70,000 | $0 | $1.41M | 0.09% | +$1.41M |
| Research Alliance Corp IiiCL A | 370,000 | 125,000 | -245,000 | $3.96M | $1.35M | 0.09% | -$2.61M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 175,000 | 50,000 | -125,000 | $4.59M | $1.32M | 0.09% | -$3.27M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 50,000 | 15,000 | -35,000 | $4.08M | $981.8K | 0.07% | -$3.09M |
| Cogent Biosciences, Inc.(COGT) | 100,000 | 30,000 | -70,000 | $3.87M | $960.6K | 0.06% | -$2.91M |
| Structure Therapeutics IncADS | 75,000 | 30,000 | -45,000 | $4.03M | $938.1K | 0.06% | -$3.09M |
| Vaxcyte, Inc.(PCVX) | 50,000 | 15,000 | -35,000 | $2.91M | $853.5K | 0.06% | -$2.05M |
| Quince Therapeutics Inc | 5,498 | 5,498 | 0 | $100.0K | $170.5K | 0.01% | +$70.5K |
| Altimmune, Inc.(ALT) | 1,250,000 | 0 | -1,250,000 | $3.80M | $0 | — | -$3.80M |
| Crinetics Pharmaceuticals In | 125,000 | 0 | -125,000 | $4.68M | $0 | — | -$4.68M |
| Damora Therapeutics, Inc.(DMRA) | 1,000,000 | 0 | -1,000,000 | $26.01M | $0 | — | -$26.01M |